Observational studyVascular health and risk management2015

Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study.

Charles Saab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.